Plain-English translation of NCT05963126 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying a protein called Fetuin A that appears in urine. They believe this protein might help doctors catch kidney damage early in people with high blood pressure — before the usual blood and urine tests show problems. The study will enroll 200 patients with different types of high blood pressure to see if measuring this protein in the urine could become a new warning sign for future kidney disease.
High blood pressure is one of the leading causes of kidney disease, but by the time standard kidney tests show damage, it may be too late to prevent serious harm. This research is looking for an earlier warning signal so doctors can intervene sooner and protect patients' kidneys.
You likely qualify if…
You likely don't qualify if…
This is an observational study, meaning researchers will monitor you rather than give you a new medication to test. You will be asked to provide urine and blood samples so doctors can measure the Fetuin A protein and check your kidney function. The study compares people with regular high blood pressure, resistant high blood pressure (hard to control), and secondary high blood pressure to understand how this protein behaves in each group.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Czechia
Sponsor
University Hospital Ostrava
Enrollment target
~200 participants
Started
July 2023
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 100 Years
Last updated on clinicaltrials.gov in July 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jiří Hynčica
University Hospital Ostrava
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.